Read More

Opiant Pharmaceuticals Announces CFIUS Approval For Proposed Acquisition By Indivior PLC; Under The Terms Of The Agreement, Indivior Will Acquire All The Outstanding Shares Of Opiant For Upfront Consideration Of $20.00 Per Share In Cash At Closing

CFIUS clearance represents the final required regulatory approval to complete the proposed merger   Completion remains subject to the approval of Opiant stockholders; a special stockholder meeting to approve

OPNT

Read More

Reported Late Monday Feb 6, LanzaTech Announces AMCI Stockholder Approval For Their Business Combination As Well As Additional PIPE Investments And Forward Purchase Agreement; Entered Into $100M Forward Purchase Agreement To Enhance Financial Flexibili…

AMCI Stockholders have approved the previously announced business combination with LanzaTech at the Special Meeting held on February 6, 2023   Entered into $100 million forward purchase agreement to

AMCI